Home
About
Overview
Sharing Data
ORCID
Help
History (28)
Phase II trial of gemcitabine in patients with previously untreated metastatic cancer of the esophagus or gastroesophageal junction.
The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial.
Quantitative evaluation of internal marks made using MRgFUS as seen on MRI, CT, US, and digital color images - a pilot study.
HiSStology: high spectral and spatial resolution magnetic resonance imaging detection of vasculature validated by histology and micro-computed tomography.
Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer.
See All 28 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer.
Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer. J Clin Oncol. 2005 Nov 01; 23(31):8033-40.
View in:
PubMed
subject areas
Adenocarcinoma
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antineoplastic Combined Chemotherapy Protocols
Bevacizumab
Deoxycytidine
Disease Progression
Disease-Free Survival
Female
Humans
Liver Neoplasms
Lung Neoplasms
Male
Middle Aged
Pancreatic Neoplasms
Peritoneal Neoplasms
Survival Rate
Treatment Outcome
Vascular Endothelial Growth Factor A
authors with profiles
Hedy Kindler
Mark Kozloff
Abraham Dachman
Everett Vokes
Theodore Karrison